HK1183058A1 - Bifidobacterium having activity of reducing amount of intestinal putrefacted substance - Google Patents

Bifidobacterium having activity of reducing amount of intestinal putrefacted substance

Info

Publication number
HK1183058A1
HK1183058A1 HK13110266.1A HK13110266A HK1183058A1 HK 1183058 A1 HK1183058 A1 HK 1183058A1 HK 13110266 A HK13110266 A HK 13110266A HK 1183058 A1 HK1183058 A1 HK 1183058A1
Authority
HK
Hong Kong
Prior art keywords
putrefacted
bifidobacterium
intestinal
substance
activity
Prior art date
Application number
HK13110266.1A
Other languages
Chinese (zh)
Inventor
天藤公子
Original Assignee
株式會社明治
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式會社明治 filed Critical 株式會社明治
Publication of HK1183058A1 publication Critical patent/HK1183058A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/127—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
HK13110266.1A 2010-07-05 2013-09-03 Bifidobacterium having activity of reducing amount of intestinal putrefacted substance HK1183058A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010152962 2010-07-05
PCT/JP2011/065350 WO2012005240A1 (en) 2010-07-05 2011-07-05 Bifidobacterium having activity of reducing amount of intestinal putrefacted substance

Publications (1)

Publication Number Publication Date
HK1183058A1 true HK1183058A1 (en) 2013-12-13

Family

ID=45441219

Family Applications (2)

Application Number Title Priority Date Filing Date
HK13110266.1A HK1183058A1 (en) 2010-07-05 2013-09-03 Bifidobacterium having activity of reducing amount of intestinal putrefacted substance
HK16109893.1A HK1221748A1 (en) 2010-07-05 2016-08-18 Bifidobacterium having activity of reducing amount of intestinal putrefacted substance

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16109893.1A HK1221748A1 (en) 2010-07-05 2016-08-18 Bifidobacterium having activity of reducing amount of intestinal putrefacted substance

Country Status (4)

Country Link
JP (2) JP5837879B2 (en)
CN (2) CN102959075B (en)
HK (2) HK1183058A1 (en)
WO (1) WO2012005240A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104988104B (en) * 2015-08-13 2017-12-26 山东凤凰生物有限公司 One plant has the lactic acid bacteria adsorbed or degrade enterotoxin function and its application
CN106819107A (en) * 2016-12-29 2017-06-13 石家庄君乐宝乳业有限公司 Leben with the effect of whole intestines and preparation method thereof
JP2018177752A (en) * 2017-04-18 2018-11-15 国立大学法人東北大学 Blood purification by alkalizing agent
JP7219898B2 (en) * 2017-04-18 2023-02-09 国立大学法人東北大学 Blood purification with alkaline agents
WO2018193648A1 (en) * 2017-04-18 2018-10-25 国立大学法人東北大学 Blood purification through alkalifying agent
JP7309436B2 (en) * 2019-04-26 2023-07-18 森永乳業株式会社 A composition for preventing or improving renal dysfunction, and pharmaceutical compositions and food and drink compositions using the composition for preventing or improving renal dysfunction
MX2022004635A (en) * 2019-10-21 2022-05-10 Biofermin Pharmaceutical Co Ltd Uremic toxin reducing agent.
JP2022072243A (en) 2020-10-29 2022-05-17 帝人株式会社 Composition for improving intestinal bacterial flora, and composition for inhibiting production of intestinal putrefactive substance
CN113005049B (en) * 2020-12-30 2022-11-01 江南大学 Bifidobacterium breve capable of relieving diarrhea and application thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3209784B2 (en) * 1992-02-27 2001-09-17 高梨乳業株式会社 New Lactobacillus microorganisms
JPH0856650A (en) * 1994-08-29 1996-03-05 Meiji Seito Kk New lactic acid bacterium
JP3530674B2 (en) * 1996-03-04 2004-05-24 明治乳業株式会社 Mutagenic substance absorption inhibitory food
JPH11113564A (en) * 1997-10-14 1999-04-27 Taiyo Corp New lactic bacterium having antimutagenic and food containing the same
SE526711C2 (en) * 2003-01-31 2005-10-25 Probi Ab Novel strains of Bifidobacterium having ability to survive in intestinal tract and produce glutamine and arginine in vivo, useful for preparing medicament for treatment of intensive care patients with intestinal failure
JP2004277296A (en) * 2003-03-13 2004-10-07 Morishita Jintan Kk Lactic acid bacterium-containing enteric pharmaceutical preparation
JP2006158216A (en) * 2004-12-02 2006-06-22 Miyarisan Kk Microorganism having function of reducing indole
EP2059585A2 (en) * 2006-08-18 2009-05-20 OrganoBalance GmbH Probiotic microorganisms for the reduction of manure odor

Also Published As

Publication number Publication date
CN102959075B (en) 2016-03-02
CN105671120A (en) 2016-06-15
CN105671120B (en) 2019-02-19
CN102959075A (en) 2013-03-06
JP6096263B2 (en) 2017-03-15
HK1221748A1 (en) 2017-06-09
WO2012005240A1 (en) 2012-01-12
JP2016028595A (en) 2016-03-03
JPWO2012005240A1 (en) 2013-09-02
JP5837879B2 (en) 2015-12-24

Similar Documents

Publication Publication Date Title
HK1221748A1 (en) Bifidobacterium having activity of reducing amount of intestinal putrefacted substance
GB2496547B (en) Optimization of human activity determination from video
ZA201304280B (en) Treatment of jak2-mediated conditions
HK1178149A1 (en) Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use -4---
PT2750682T (en) Composition comprising anaerobically cultivated human intestinal microbiota
ZA201209407B (en) Modification of xylan
EP2601279A4 (en) Supertorrefaction of biomass into biocoal
EP2563768A4 (en) Preparation of febuxostat
TWM389943U (en) Application structure of connector
TWM385548U (en) Improved structure of conveyor
EP2536688A4 (en) Stable dosage forms of levomilnacipran
EP2603230A4 (en) Use of blood group status
TWM386182U (en) Improved structure of seal
TWM390860U (en) Structure of granulator
TWM388919U (en) Structure of endoscope
TWM386637U (en) Improved structure of connector
TWM387405U (en) Improved structure of connector
TWM363914U (en) Improved structure of medicine case
TWM401364U (en) Improved structure of sofa
TWM389548U (en) Improved structure of soft capsule
TWM390349U (en) Structure of door-in-door
TWM386865U (en) Residue-filtering structure of juice-extractor
TWM400763U (en) Improved structure of cold-accumulating cravats
TWM388315U (en) Improved structure of hemoclip
TWM402612U (en) Improved structure of connection member